medicine
Our medicine
Ribotix
Ribociclib
Ribociclib 200 mg (Ribotix) is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
Talk to us
Have any questions? We are always open to talk about your business, new projects, creative opportunities and how we can help you.